Blue Stream Laboratories Adds Capacity to Accommodate Continued Growth in Biosimilars
Will Exhibit at Booth 8 at Well Characterized Biologicals, Nov. 9-10 in Reston, VA
(firmenpresse) - WOBURN, MA -- (Marketwired) -- 11/04/15 -- , an advanced analytical laboratory specializing in recombinant glycoprotein and complex biologics characterization services, is expanding into new office and lab space, adjacent to its current facility, to handle the continued growth of its . Last year, the company moved into new space in Woburn to double the capacity of its prior Cambridge facility.
Blue Stream will exhibit at Booth 8 at the Well Characterized Biologicals Conference from Nov. 9-10 at the Hyatt Regency Reston VA.
Having provided characterization services for 10 of the top biosimilar products in development, Blue Stream offers a complete suite of analytical solutions for biosimilar product development from initial product screening to biosimilar/originator comparability to comprehensive characterization including primary and secondary/tertiary structure, glycosylation/PTMs, and activity.
The biosimilar segment continues to perform well for the company. In 2014, Blue Stream recorded a 60 percent increase in revenue over the prior year, along with a 50 percent increase in facility size, and a 30 percent expansion of its research and development capabilities. This growth was significantly driven by Blue Stream''s biosimilars services.
"The market for biosimilars continues to grow, with consensus of reaching at least $20 billion within the next few years. Blue Stream has significant biosimilar expertise, and we continue to invest in the people, equipment and infrastructure to develop innovative methods, improve quality and extend our expertise," said of Blue Stream Laboratories.
Blue Stream Laboratories is an advanced analytical laboratory specializing in recombinant glycoprotein and complex biologics characterization services. Blue Stream supports Pre-IND through cGMP clinical phase product development programs for product characterization, cGMP lot release, and stability program support. Located 10 miles outside of Boston, and serving companies throughout the U.S. and overseas, Blue Stream''s clients range from small start-ups and virtual biotechs to Fortune 500 pharmaceutical and medical device companies. For more information, please visit the company website at .
Norman Birnbach
Birnbach Communications
781-639-6701
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 04.11.2015 - 09:01 Uhr
Sprache: Deutsch
News-ID 1396895
Anzahl Zeichen: 3157
contact information:
Contact person:
Town:
WOBURN, MA
Phone:
Kategorie:
Drugs
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 251 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Blue Stream Laboratories Adds Capacity to Accommodate Continued Growth in Biosimilars
"
steht unter der journalistisch-redaktionellen Verantwortung von
Blue Stream Laboratories (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
